3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
13
Urinary Bladder Neoplasms
12
Kidney Neoplasms
7
Carcinoma, Renal Cell
6
Urethral Neoplasms
2
Carcinoma, Transitional Cell
2
Wilms Tumor
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Testicular Neoplasms
1
Seminoma
1
Prostate Adenocarcinoma
1
Penile Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Muscle Invasive Bladder Cancer
1
Graft vs Host Disease
1
Genomic Instability
1
Interventions
tislelizumab
2
Cystectomy
2
vistusertib
1
toripalimab
1
olaparib
1
liposomal doxorubicin
1
durvalumab
1
disitamab vedotin
1
danvatirsen
1
adavosertib
1
Surgical Procedures, Operative
1
Rutin
1
Radiation
1
RC48 antibody
1
Neoadjuvant Therapy
1
Gemcitabine
1
Cisplatin
1
Chemoradiotherapy
1
AZD4547
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Muscle Invasive Bladder Cancer
×
Neoadjuvant Therapy
×
Genitourinary
×
Clear all
NCT07202819
2025-10-02
"NAC-MRI"
Assiut University
Phase NA
Recruiting
76 enrolled